AgomAb Therapeutics NV

AGMB·NasdaqGS·Healthcare
Compare
6.850.00 (0.00%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close6.85
Open7.00
Day range6.767.09
52-week range6.5217.82
Off day high−3.32%
Off 52-week high−61.56%
Volume79.98K
Avg. volume (3M)147.57K
Market cap337.35M
EPS (TTM)-2.08
Forward P/E-3.38
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding49.25M
Short interest2.31% of float
Earnings date—
Analyst target37.67
Profit margin0.00%

Against its peers

Compare in full ›
AGMB AVBP IMRX GPCR ACRS SNDX
Market cap 337.35M 665.16M 243.51M 1.45B 570.34M 940.80M
P/E (TTM) — — — — — —
Forward P/E -3.4 -3.6 -3.0 -9.6 -5.1 -14.4
Price/book 2.7 1.8 1.4 1.1 4.1 -54.7
Dividend yield — — — — — —
1-year change −53.24% −28.97% −42.59% −36.82% +65.49% −5.36%
Today 0.00% +3.61% +2.17% +0.05% −1.60% −26.87%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All AGMB news ›
Stock Titan·

AgomAb Therapeutics director Epstein buys shares

Purchases on October 5 and 6, 2026, were priced at $8.57 and $8.70 per share, respectively. No Rule 10b5-1 plan was reported for either. - [Form 4] AgomAb Therapeutics NV Insider Trading Activity AgomAb Therapeutics director Epstein buys…

Stock Titan·

AgomAb Therapeutics CFO buys 10,000 common shares

Pierre Thadee Victor Kemula bought shares directly on October 6, 2026, at $8.54–$8.67 per share. No Rule 10b5-1 plan is reported. - [Form 4] AgomAb Therapeutics NV Insider Trading Activity AgomAb Therapeutics CFO buys 10,000 common shares…

Stock Titan·Positive

AgomAb Therapeutics starts ontunisertib Phase 2b trial

Press Release QNX Research Finds Automotive Developers Spend More than a Third of Their Time on Software "Plumbing" Slowing SDV Innovation Smith & Wesson Acquires Savage Arms NOV-ERA uses 1:1:1:1 randomization and includes a six-week…

From the 4Search news index, newest first.

In the news

6mentions in 30 days
6with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance